James Dale

Targeting ultrasound remission in early rheumatoid arthritis: the results of the TaSER study, a randomised clinical trial

James Dale, A. Stirling, Ruiqi Zhang et al. · Annals of the Rheumatic Diseases · 2016 · 214 citations

Tumour necrosis factor inhibition versus rituximab for patients with rheumatoid arthritis who require biological treatment (ORBIT): an open-label, randomised controlled, non-inferiority, trial

Duncan Porter, Jurgen van Melckebeke, James Dale et al. · The Lancet · 2016 · 118 citations · Full text

Inflammation, Rheumatology, Biological Treatment +11

Tightening Up? Impact of Musculoskeletal Ultrasound Disease Activity Assessment on Early Rheumatoid Arthritis Patients Treated Using a Treat to Target Strategy

James Dale, David Purves, Alex McConnachie et al. · Arthritis Care & Research · 2013 · 60 citations

Changes in Plasma Itaconate Elevation in Early Rheumatoid Arthritis Patients Elucidates Disease Activity Associated Macrophage Activation

Rónán Daly, Gavin Blackburn, Cameron Best et al. · Metabolites · 2020 · 41 citations · Full text

Immunology, Inflammation, Rheumatoid Disorder +19

Brief Report: Predicting Functional Disability: One‐Year Results From the Scottish Early Rheumatoid Arthritis Inception Cohort

Caroline Kronisch, David J. McLernon, James Dale et al. · Arthritis & Rheumatology · 2016 · 36 citations